Nymox的立场是,澄清问题仍需在后续会议上解决,并涉及一些重大的不一致之处。...查看全文
耐莫斯制药(NYMX)2023-06-30 04:35
$耐莫斯制药(NYMX)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001155 Act: 34 Size: 10 KB 网页链接查看全文
耐莫斯制药(NYMX)2023-06-30 05:25
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001158 Act: 34 Size: 10 KB 网页链接查看全文
耐莫斯制药(NYMX)2023-07-06 18:05
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001216 Act: 34 Size: 27 KB 网页链接查看全文
耐莫斯制药(NYMX)2023-06-28 05:25
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001135 Act: 34 Size: 9 KB 网页链接查看全文
耐莫斯制药(NYMX)2023-06-26 22:35
$耐莫斯制药(NYMX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001729637-23-000006 Size: 6 KB 网页链接查看全文
耐莫斯制药(NYMX)2023-05-19 04:15
$耐莫斯制药(NYMX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001729637-23-000003 Size: 4 KB 网页链接查看全文
耐莫斯制药(NYMX)2023-05-15 17:07
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-000844 Act: 34 Size: 1 MB 网页链接查看全文
耐莫斯制药(NYMX)2023-05-13 04:57
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-000844 Act: 34 Size: 1 MB 网页链接查看全文
耐莫斯制药(NYMX)2023-05-02 20:36
$耐莫斯制药(NYMX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001640334-23-000736 Act: 34 Size: 5 MB 网页链接查看全文
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001216 Act: 34 Size: 27 KB 网页链接
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001158 Act: 34 Size: 10 KB 网页链接
$耐莫斯制药(NYMX)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001155 Act: 34 Size: 10 KB 网页链接
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-001135 Act: 34 Size: 9 KB 网页链接
$耐莫斯制药(NYMX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001729637-23-000006 Size: 6 KB 网页链接
$耐莫斯制药(NYMX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001729637-23-000003 Size: 4 KB 网页链接
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-000844 Act: 34 Size: 1 MB 网页链接
$耐莫斯制药(NYMX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001640334-23-000844 Act: 34 Size: 1 MB 网页链接
$耐莫斯制药(NYMX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001640334-23-000736 Act: 34 Size: 5 MB 网页链接
$耐莫斯制药(NYMX)$ NT 20-F Notification of inability to timely file Form 20-F Accession Number: 0001640334-23-000534 Act: 34 Size: 35 KB 网页链接